Fluidigm Imaging Mass Cytometry Discovers Tumor Microenvironment Features Predicting Lung Cancer Outcomes Researchers applied a deep-learning approach to generate a model to predict lung cancer progression based on the tumor microenvironment. Standard BioTools to Restructure, Discontinue Certain Products as Q2 Revenues Drop 39 Percent The company's Q2 revenues fell 39 percent, and its net loss more than tripled as it continues to implement a new corporate strategy initiated earlier this year. Standard BioTools Q1 Revenues Fall 19 Percent In Q1 the company formerly known as Fluidigm completed a strategic evaluation process and closed a $250 million capital infusion from Casdin Capital and Viking Global Investors. Spatial Proteomics Releases at AACR Offer Increases in Multiplexing, Throughput Premium Companies including Bruker, Akoya, and Standard BioTools either released new platforms or highlighted advances in their systems' capabilities at the meeting. Fluidigm Appeal in IonPath Patent Infringement Battle Voluntarily Dismissed The verdict seemingly closes a lawsuit filed by Fluidigm against IonPath in 2019 for allegedly infringing patents covering Fluidigm's mass cytometry technology. Feb 22, 2022 Broad Institute, Collaborators Eye CRISPR Panel to Detect SARS-CoV-2 Variants, Respiratory Viruses Premium Feb 18, 2022 Fluidigm Q4 Revenues Down 14 Percent as COVID-19 Testing Revenue Declines Feb 17, 2022 Fluidigm Partners With Abu Dhabi Stem Cells Center on Therapy Development, Research Feb 11, 2022 Fluidigm, Uh-Oh Labs Get Emergency Use Authorization for COVID-19 Tests Jan 11, 2022 Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results Nov 12, 2021 New Products Posted to GenomeWeb: Fluidigm, GenScript, Biognosys, More Nov 8, 2021 Fluidigm Q3 Revenues Drop 29 Percent on Supply Chain Issues, Waning COVID-19 Testing Nov 1, 2021 GenomeWeb Index Bounces Back in October, Led by Rebound in Berkeley Lights Stock Aug 5, 2021 Fluidigm Q2 Revenues Grow 19 Percent Aug 5, 2021 Fluidigm Inks Comarketing Pacts With Ultivue, ImaBiotech Aug 2, 2021 GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases Jun 1, 2021 GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April May 28, 2021 New Products Posted to GenomeWeb: Fluidigm, Waters, MicroGenDx, More May 6, 2021 Fluidigm Q1 Revenues Grow 19 Percent Mar 24, 2021 DARPA Programs Leveraging Host-Response Testing, CRISPR for Future Pandemic Preparedness Premium Mar 2, 2021 Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent Mar 1, 2021 FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit Feb 19, 2021 Fluidigm Loses Patent Suit Against IonPath Feb 11, 2021 Fluidigm CEO Lays Out Plan for 'Durable' Diagnostics, Clinical Business Post-COVID Premium Feb 10, 2021 Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.